 |
|
Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6
Mun Hyuk Seong, Ho Kil, Jong Yeop Kim, Sang Soo Lee, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Haesun Yun, Byung Hak Kang, Kisang Kim
Clin Mol Hepatol. 2013;19(1):45-50. Published online 2013 Mar 25 DOI: https://doi.org/10.3350/cmh.2013.19.1.45
|
|
Citations to this article as recorded by
 Analysis of Hepatitis C Virus Genotypes and RNA Quantitative Values in Cheonan, Republic of Korea from 2007 to 2016
Bishguurmaa Renchindorj, Bo Kyeung Jung, Joowon Park
Microbiology and Biotechnology Letters.2022; 50(3): 422. CrossRef Systematic review: epidemiology and response to direct‐acting antiviral therapy in genotype 6 chronic hepatitis C virus infection
Panita Mettikanont, Chalermrat Bunchorntavakul, K. Rajender Reddy
Alimentary Pharmacology & Therapeutics.2019; 49(5): 492. CrossRef Analysis of HCV RNA Genotypes and Quantitative Values of Korean HCV NAT Reactive Blood Donors
Sunmi Shin, Jae-won Kang, Jungwon Kang, Young Ik Seo, Jung Ran Park, Dae Dong Lee, Hyukki Min, Myunghan Kim
The Korean Journal of Blood Transfusion.2019; 30(3): 205. CrossRef Molecular characterization of hepatitis C virus genotype 6 subtypes in Thai blood donors
Anchalee Sistayanarain, Suriya Chaiwong
Journal of Microbiology, Immunology and Infection.2017; 50(1): 26. CrossRef Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study
Su Rin Shin, Young Seok Kim, Young-Seok Lim, June Sung Lee, Jin Woo Lee, Sun Myung Kim, Sook-Hyang Jeong, Joo Hyun Sohn, Myung Seok Lee, Sang Hoon Park
Gut and Liver.2017; 11(2): 270. CrossRef Public participation in decision-making on the coverage of new antivirals for hepatitis C
Katharina Kieslich, Peter Littlejohns and Albert Weale, Katharina Kieslich, Jeonghoon Ahn, Gabriele Badano, Kalipso Chalkidou, Leonardo Cubillos, Renata Curi Hauegen, Chris Henshall, Carleigh B Krubiner, Peter Littlejohns, Lanting Lu, Steven D Pearson, An
Journal of Health Organization and Management.2016; 30(5): 769. CrossRef The Applications of Hepatitis C Virus (HCV) Replication System in Developing Anti-HCV Reagents
Hyosun Cho
Journal of Bacteriology and Virology.2015; 45(2): 171. CrossRef Epidemiology of Hepatitis C Virus Infection in Korea
Sook-Hyang Jeong
Korean Journal of Medicine.2015; 88(6): 630. CrossRef Prevalence, Risk Factors and Clinical Characteristics in Patients with Genotype 6 Chronic Hepatitis C: A Single Institute Experience
Seung Kak Shin, Soo Yong Park, Young Kul Jung, Eui Joo Kim, Heon Nam Lee, Jong Joon Lee, Oh Sang Kwon, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
The Korean Journal of Gastroenterology.2015; 65(2): 105. CrossRef Current Treatment Options in Patients with Hepatitis C Virus Genotype 6
Nghia H. Nguyen, Mindie H. Nguyen
Gastroenterology Clinics of North America.2015; 44(4): 871. CrossRef Meta-Analysis: Superior Treatment Response in Asian Patients with Hepatitis C Virus Genotype 6 versus Genotype 1 with Pegylated Interferon and Ribavirin
Nghia H. Nguyen, Shelley A. McCormack, Philip Vutien, Brittany E. Yee, Pardha Devaki, David Jencks, Mindie H. Nguyen
Intervirology.2015; 58(1): 27. CrossRef Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks
Nghia H. Nguyen, Shelley A. McCormack, Brittany E. Yee, Pardha Devaki, David Jencks, David T. Chao, Mindie H. Nguyen
Hepatology International.2014; 8(4): 540. CrossRef
|